Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by European Renal Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Renal Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#40 Avacopan in ANCA-Associated Vasculitis, with Lorraine Harper

21:57
 
Share
 

Manage episode 476172555 series 3548026
Content provided by European Renal Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Renal Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Steroids have long been a cornerstone in treating ANCA-associated vasculitis, but their toxicity remains a significant challenge. Could Avacopan, a selective oral C5a receptor antagonist, provide a safer and more effective alternative? In this episode, you’ll hear about what’s new in the pathophysiology of ANCA vasculitis, current remission induction therapies, the place of Avacopan in the treatment protocols and future possibilities for managing this complex condition. Guiding us through these topics is Lorraine Harper, a distinguished specialist from the University of Birmingham, whose expertise in immunology and vasculitis offers invaluable insights into the latest advancements.

  continue reading

88 episodes

Artwork
iconShare
 
Manage episode 476172555 series 3548026
Content provided by European Renal Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Renal Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Steroids have long been a cornerstone in treating ANCA-associated vasculitis, but their toxicity remains a significant challenge. Could Avacopan, a selective oral C5a receptor antagonist, provide a safer and more effective alternative? In this episode, you’ll hear about what’s new in the pathophysiology of ANCA vasculitis, current remission induction therapies, the place of Avacopan in the treatment protocols and future possibilities for managing this complex condition. Guiding us through these topics is Lorraine Harper, a distinguished specialist from the University of Birmingham, whose expertise in immunology and vasculitis offers invaluable insights into the latest advancements.

  continue reading

88 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play